Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Non-cash Items (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Non-cash Items for 3 consecutive years, with $412000.0 as the latest value for Q4 2025.

  • Quarterly Non-cash Items fell 94.21% to $412000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $412000.0 through Dec 2025, down 94.21% year-over-year, with the annual reading at $412000.0 for FY2025, 94.21% down from the prior year.
  • Non-cash Items for Q4 2025 was $412000.0 at Artiva Biotherapeutics, down from $6.7 million in the prior quarter.
  • The five-year high for Non-cash Items was $17.3 million in Q3 2024, with the low at $214000.0 in Q4 2023.
  • Average Non-cash Items over 3 years is $5.8 million, with a median of $6.7 million recorded in 2025.
  • The sharpest move saw Non-cash Items skyrocketed 3226.17% in 2024, then tumbled 94.21% in 2025.
  • Over 3 years, Non-cash Items stood at $214000.0 in 2023, then surged by 3226.17% to $7.1 million in 2024, then crashed by 94.21% to $412000.0 in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $412000.0, $6.7 million, and $7.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.